Veracyte reported $219.5M in Cash and Equivalent for its fiscal quarter ending in June of 2025.




Cash And Equivalent Change Date
Agilent USD 1.54B 49M Jul/2025
Arrowhead Research USD 129.79M 55.92M Jun/2025
Bruker USD 92M 92.2M Jun/2025
Exact Sciences USD 657.1M 650.98M Jun/2025
Illumina USD 934M 179M Jun/2025
Laboratory Of America USD 647.3M 277.9M Jun/2025
Ligand Pharmaceuticals USD 67.67M 189.22M Jun/2025
Myriad Genetics USD 91.8M 10.6M Mar/2025
Roche Holding CHF 6.98B 2.15B Dec/2024
Siemens EUR 14.64B 1.96B Jun/2025
Sonic Healthcare AUD 645M 25.39M Jun/2024
Thermo Fisher Scientific USD 4.58B 442M Jun/2025
Veracyte USD 219.5M 33.38M Jun/2025
Waters USD 367.22M 15.66M Jun/2025